• Castellano
  • English
  • Valenciá
Página de inicio de ReDivia
Página de la Generalitat ValenciáPágina de IVIA
Visualitza element 
  •   Inici de ReDivia
  • 1.- Investigación
  • 1.1.- Artículos de revista académica
  • Visualitza element
  •   Inici de ReDivia
  • 1.- Investigación
  • 1.1.- Artículos de revista académica
  • Visualitza element
JavaScript is disabled for your browser. Some features of this site may not work without it.

Viability of ICSI oocytes after caffeine treatment and sperm membrane removal with Triton X-100 in pigs

Exporta
untranslatedRefworks
URI
http://hdl.handle.net/20.500.11939/5251
DOI
10.1016/j.theriogenology.2011.06.030
Derechos de acceso
openAccess
Metadades
Mostra el registre complet de l'element
Autor/a
García-Mengual, Elena; Garcia-Rosello, E.; Alfonso, J.; Salvador, I.; Cebrián-Serrano, Alberto; Silvestre, Miguel A.
Data
2011
Cita bibliográfica
Garcia-Mengual, E., Garcia-Rosello, E., Alfonso, J., Salvador, I., Cebrian-Serrano, A., Silvestre, M.A. (2011). Viability of ICSI oocytes after caffeine treatment and sperm membrane removal with Triton X-100 in pigs. Theriogenology, 76(9), 1658-1666.
Resum
Non-adequate decondensation of injected sperm nucleus is one the main problems of intracytoplasmic sperm injection (ICSI) in porcine. With the aim of improving pronuclear formation, the effects on activation and embryo development rates of 0.1% Triton X-100 (TX) sperm pre-treatment for membrane removal and/or 5 mM Caffeine (CAF) addition in oocyte manipulating and culture medium for 2 h after ICSI or artificial activation were studied. The effects of 4 different Ca(2+) concentrations contained in the injection medium on embryo development after sham injection were also analysed. In Experiment 1, no significant effect on cleavage or blastocyst rate was detected independently of Ca(2+) concentration contained in the injection medium. in Experiment 2, oocytes injected with TX pre-treated sperm showed a significant higher rate of male pronuclear formation in comparison with oocytes from control group (2PN; 54.1 vs 36.6%). However, no differences on in vitro embryo development, cleavage or blastocyst rates were observed. In Experiment 3, oocytes treated with CAF during and after micromanipulation and injected with sperm pre-treated with TX had a significantly lower oocyte activation rate than any other experimental groups (25.7 vs 56.3-66.3%). No differences were observed in cleavage rates among different experimental groups. However, the CAF group showed a higher blastocyst rate significantly different from TX+CAF group (12.0 vs 1.9%, respectively). In a second approach, the effect of electric field strengths and CAF treatments on oocyte activation was studied. In Experiment 4, oocytes submitted to 0.6 kV/cm showed significant higher activation rates than 1.2 kV/cm ones regardless of the caffeine treatment (83.7 vs 55.9% and 75.7 vs 44.3%; in control and caffeine groups, respectively). No effect of caffeine treatment was observed in any experimental group. In conclusion, TX sperm treatment before ICSI without an additional activation procedure improved male pronuclear formation, but did not improve embryo development until blastocyst stage. No significant effect of caffeine was found when sperm was not treated with TX, although in membrane absence caffeine avoided oocyte activation and embryo development. Finally, caffeine had no effect on female pronuclear formation regardless of electric field strengths applied to the parthenogenetic activation. (C) 2011 Elsevier Inc. All rights reserved.
Col·leccions
  • 1.1.- Artículos de revista académica

Visualitza

Tot ReDiviaComunitats i col·leccionsPer data de publicacióAutor/aTítolsMatèriesTemesCentres IVIAAquesta col·leccióPer data de publicacióAutor/aTítolsMatèriesTemesCentres IVIA

El meu compte

EntraRegistre

Estadístiques

Vegeu Estadístiques d'ús

D'interès

Política d'Accés Obert de l'IVIAPropietat intel·lectual i drets d'autorAutoarxiuPreguntes freqüents

Indexadores

Recolectauntranslated

El contenido de este sitio está bajo una licencia Creative Commons - No comercial - Sin Obra Derivada (by-nc-nd), salvo que se indique lo contrario.